Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety

Advancements in rheumatoid arthritis (RA) treatment protocols and introduction of targeted biological therapies have markedly improved patient outcomes, despite this, up to 50% of patients still fail to achieve a significant clinical response. In veterinary medicine, stem cell therapy in the form of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rodriguez, Jorge Paz, Murphy, Michael P, Hong, Soonjun, Madrigal, Marialaura, March, Keith L, Minev, Boris, Harman, Robert J, Chen, Chien-Shing, Timmons, Ruben Berrocal, Marleau, Annette M, Riordan, Neil H
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2012
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3296619/
https://ncbi.nlm.nih.gov/pubmed/22313603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-7682-5-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires